Advertisement
News
Advertisement

Momenta stock down after greater-than-expected Q3 loss

Wed, 11/07/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Stock value for Momenta Pharmaceuticals Inc. (Nasdaq:MNTA) fell nearly 10 percent Wednesday after the company announced a net loss for the three months that ended in September that was nearly twice as much as analysts expected.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading